These drugs were hailed by proponents as breakthroughs in the fight to treat Alzheimer’s disease, but a new independent review finds they make “no meaningful difference”
These drugs were hailed by proponents as breakthroughs in the fight to treat Alzheimer’s disease, but a new independent review finds they make “no meaningful difference”